Huaxin Sheng, M.D., is an Associate Professor of anesthesiology and Codirector of the Multidisciplinary Neuroprotection Laboratories at Duke University Medical Center, Durham, NC, USA. He graduated from the Nantong University School of Medicine, China, in 1984, and completed residency training at the Hebei Medical University Hospital, China, in 1992, and a fellowship at the Duke University Medical Center, in 1996. He joined the Department of Anesthesiology as a faculty member in 1999 and focused on studying the effects of anesthetic agents on ischemic brain injury, which is a potential surgical risk from cardiopulmonary bypass and other surgical procedures. Currently, he is dedicated to translational research in the field of brain and spinal cord injuries and leading several projects supported by the NIH and pharmaceutical companies. His major interest is to develop a new strategy on ameliorating the oxidative/nitrosative stress resulting from brain and spinal cord injuries, reducing tissue damage and promoting neurologic and cognitive function recovery. He has published 60 peer-reviewed articles and filed three pending patents in treating neurological diseases, such as stroke, head trauma, spinal cord ischemia, cerebral arterial vasospasm, and neonatal hypoxia. He also is an Active Ad Hoc Reviewer for multiple journals (e.g., Anesthesia & Analgesia, Neurocritical Care, Journal of Neurotrauma, British Journal of Pharmacology, European Journal of Clinical Investigation, and Journal of Signal Transduction) and several funding agencies (e.g., MRC and CDMRP).
Biography Updated on 30 August 2011